GlassScriptPhysician profile
Hannah Butler
NPI 1114475795
$3,194.75
in general payments reported to CMS, 2019-2025
40 companies · $1,334 in 2025
The $1,334 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $54.16 · 2022: $105 · 2023: $496 · 2024: $1,206 · 2025: $1,334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,035.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $393.91 | 2021-2025 | Jakafi, Monjuvi, Niktimvo |
| Novartis Pharmaceuticals Corporation | $330.04 | 2023-2025 | |
| Celgene Corporation | $316.33 | 2022-2025 | Reblozyl, Breyanzi, Onureg |
| Abbvie INC. | $238.34 | 2023-2025 | |
| Genentech USA, INC. | $237.08 | 2023-2025 | Polivy, Venclexta, Lunsumio |
| Janssen Biotech, INC. | $133.23 | 2023-2025 | Carvykti, Tecvayli, Talvey |
| Sanofi-Aventis U.S. LLC | $112.44 | 2024-2025 | |
| Adc Therapeutics America, INC. | $110.98 | 2023-2025 | |
| Genmab U.S., INC. | $99.57 | 2023-2025 | Epkinly |
| Legend Biotech USA INC. | $99.17 | 2024-2025 | Carvykti |
| Astellas Pharma US INC | $81.49 | 2024-2025 | Cresemba |
| Alexion Pharmaceuticals, INC. | $72.66 | 2023-2025 | Ultomiris |
| Rigel Pharmaceuticals, INC. | $67.98 | 2024 | Tavalisse, Rezlidhia |
| Genzyme Corporation | $63.09 | 2025 | |
| Pfizer INC. | $62.26 | 2023-2024 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Butler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.